172 related articles for article (PubMed ID: 35267623)
1. Discovery of a New CaMKII-Targeted Synthetic Lethal Therapy against Glioblastoma Stem-like Cells.
Han JM; Kim YJ; Jung HJ
Cancers (Basel); 2022 Mar; 14(5):. PubMed ID: 35267623
[TBL] [Abstract][Full Text] [Related]
2. A curcumin derivative hydrazinobenzoylcurcumin suppresses stem-like features of glioblastoma cells by targeting Ca
Shin HJ; Lee S; Jung HJ
J Cell Biochem; 2019 Apr; 120(4):6741-6752. PubMed ID: 30390339
[TBL] [Abstract][Full Text] [Related]
3. Synergistic Anticancer Effect of a Combination of Berbamine and Arcyriaflavin A against Glioblastoma Stem-like Cells.
Han JM; Jung HJ
Molecules; 2022 Nov; 27(22):. PubMed ID: 36432068
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of PRMT1 Suppresses the Growth of U87MG-Derived Glioblastoma Stem Cells by Blocking the STAT3 Signaling Pathway.
Yuk N; Jung HJ
Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474197
[TBL] [Abstract][Full Text] [Related]
5. Antiangiogenic and antitumor potential of berbamine, a natural CaMKIIγ inhibitor, against glioblastoma.
Kim YJ; Han JM; Jung HJ
Biochem Biophys Res Commun; 2021 Aug; 566():129-134. PubMed ID: 34119825
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of mitochondrial UQCRB inhibits cancer stem cell-like properties in glioblastoma.
Jung N; Kwon HJ; Jung HJ
Int J Oncol; 2018 Jan; 52(1):241-251. PubMed ID: 29115404
[TBL] [Abstract][Full Text] [Related]
7. Sevoflurane modulates the cancer stem cell-like properties and mitochondrial membrane potential of glioma via Ca
Han XC; Zhang YJ; Dong X; Xing QZ; Li KH; Zhang L
Life Sci; 2020 Jul; 253():117675. PubMed ID: 32360621
[TBL] [Abstract][Full Text] [Related]
8. Glioblastoma Stem Cell-Derived Exosomes Enhance Stemness and Tumorigenicity of Glioma Cells by Transferring Notch1 Protein.
Sun Z; Wang L; Zhou Y; Dong L; Ma W; Lv L; Zhang J; Wang X
Cell Mol Neurobiol; 2020 Jul; 40(5):767-784. PubMed ID: 31853695
[TBL] [Abstract][Full Text] [Related]
9. Combined PDK1 and CHK1 inhibition is required to kill glioblastoma stem-like cells in vitro and in vivo.
Signore M; Pelacchi F; di Martino S; Runci D; Biffoni M; Giannetti S; Morgante L; De Majo M; Petricoin EF; Stancato L; Larocca LM; De Maria R; Pallini R; Ricci-Vitiani L
Cell Death Dis; 2014 May; 5(5):e1223. PubMed ID: 24810059
[TBL] [Abstract][Full Text] [Related]
10. Suberoylanilide hydroxamic acid represses glioma stem-like cells.
Hsu CC; Chang WC; Hsu TI; Liu JJ; Yeh SH; Wang JY; Liou JP; Ko CY; Chang KY; Chuang JY
J Biomed Sci; 2016 Nov; 23(1):81. PubMed ID: 27863490
[TBL] [Abstract][Full Text] [Related]
11. Anti-neoplastic activity of low-dose endothelial-monocyte activating polypeptide-II results from defective autophagy and G2/M arrest mediated by PI3K/Akt/FoxO1 axis in human glioblastoma stem cells.
Liu J; Liu L; Xue Y; Meng F; Li S; Wang P; Liu Y
Biochem Pharmacol; 2014 Jun; 89(4):477-89. PubMed ID: 24792437
[TBL] [Abstract][Full Text] [Related]
12. Upregulation of miR-181a suppresses the formation of glioblastoma stem cells by targeting the Notch2 oncogene and correlates with good prognosis in patients with glioblastoma multiforme.
Huang SX; Zhao ZY; Weng GH; He XY; Wu CJ; Fu CY; Sui ZY; Ma YS; Liu T
Biochem Biophys Res Commun; 2017 May; 486(4):1129-1136. PubMed ID: 28389242
[TBL] [Abstract][Full Text] [Related]
13. The ginsenoside metabolite compound K inhibits growth, migration and stemness of glioblastoma cells.
Lee S; Kwon MC; Jang JP; Sohng JK; Jung HJ
Int J Oncol; 2017 Aug; 51(2):414-424. PubMed ID: 28656196
[TBL] [Abstract][Full Text] [Related]
14. A novel oncolytic herpes simplex virus that synergizes with phosphoinositide 3-kinase/Akt pathway inhibitors to target glioblastoma stem cells.
Kanai R; Wakimoto H; Martuza RL; Rabkin SD
Clin Cancer Res; 2011 Jun; 17(11):3686-96. PubMed ID: 21505062
[TBL] [Abstract][Full Text] [Related]
15. R406 elicits anti-Warburg effect via Syk-dependent and -independent mechanisms to trigger apoptosis in glioma stem cells.
Sun S; Xue D; Chen Z; Ou-Yang Y; Zhang J; Mai J; Gu J; Lu W; Liu X; Liu W; Sheng L; Lu B; Lin Y; Xing F; Chen Z; Mou Y; Yan G; Zhu W; Sai K
Cell Death Dis; 2019 May; 10(5):358. PubMed ID: 31043589
[TBL] [Abstract][Full Text] [Related]
16. Engagement of cellular prion protein with the co-chaperone Hsp70/90 organizing protein regulates the proliferation of glioblastoma stem-like cells.
Iglesia RP; Prado MB; Cruz L; Martins VR; Santos TG; Lopes MH
Stem Cell Res Ther; 2017 Apr; 8(1):76. PubMed ID: 28412969
[TBL] [Abstract][Full Text] [Related]
17. Emerging targets for glioblastoma stem cell therapy.
Safa AR; Saadatzadeh MR; Cohen-Gadol AA; Pollok KE; Bijangi-Vishehsaraei K
J Biomed Res; 2016 Jan; 30(1):19-31. PubMed ID: 26616589
[TBL] [Abstract][Full Text] [Related]
18. Targeting of glioma stem-like cells with a parthenolide derivative ACT001 through inhibition of AEBP1/PI3K/AKT signaling.
Hou Y; Sun B; Liu W; Yu B; Shi Q; Luo F; Bai Y; Feng H
Theranostics; 2021; 11(2):555-566. PubMed ID: 33391492
[TBL] [Abstract][Full Text] [Related]
19. Sulforaphane suppresses the growth of glioblastoma cells, glioblastoma stem cell-like spheroids, and tumor xenografts through multiple cell signaling pathways.
Bijangi-Vishehsaraei K; Reza Saadatzadeh M; Wang H; Nguyen A; Kamocka MM; Cai W; Cohen-Gadol AA; Halum SL; Sarkaria JN; Pollok KE; Safa AR
J Neurosurg; 2017 Dec; 127(6):1219-1230. PubMed ID: 28059653
[TBL] [Abstract][Full Text] [Related]
20. Multi-kinase inhibitor C1 triggers mitotic catastrophe of glioma stem cells mainly through MELK kinase inhibition.
Minata M; Gu C; Joshi K; Nakano-Okuno M; Hong C; Nguyen CH; Kornblum HI; Molla A; Nakano I
PLoS One; 2014; 9(4):e92546. PubMed ID: 24739874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
